UNSPSC 41202061: Staphylococcus aureusserological reagents

In this classification, Staphylococcus aureus serological reagents are devices used in test to identify specific Staphylococcus aureus antibodies in serum. US FDA regulates Staphylococcus aureus serological reagents under 21 CFR 866.3700 and under FDA product code GTN.

UNSPSC 41202061 Staphylococcus aureus serological reagents is a Commodity code that in practice covers HIV, hepatitis, and syphilis serology testing reagents and related diagnostic supplies procured by state and local public health laboratories, criminal justice agencies, and educational institutions. The code's nominal scope does not align with the recent solicitations tagged under it; the recent activity centers entirely on HIV, hepatitis B and C, and syphilis diagnostics rather than Staphylococcus aureus testing. State and local buyers under this code include state departments of public health (Illinois Department of Public Health Division of Laboratories), county criminal justice agencies (Collin County Community Supervision and Corrections Department), city public health programs (City of Austin), state correctional departments (Texas Department of Criminal Justice), and higher education institutions (University of Houston). Issuers are predominantly state health and correctional authorities conducting formal competitive procurements—RFPs, IFBs, and ITBs—rather than small or fragmented jurisdictions, though emergency sole-source awards to Abbott Laboratories appear when supply chains are disrupted.

Recent activity concentrates in Texas and Illinois, with secondary activity in Florida and additional procurement from the City of Austin. Representative opportunities include the Illinois Department of Public Health's February 2026 IFB for a five-year hepatitis, HIV, and syphilis screening assay contract (due March 16, 2026) specifying fully automated combination testing with annual volumes around 13,200 HIV tests and 11,000 syphilis tests; Collin County's July 2026 RFP for offender specimen collection and drug testing services (due July 23, 2026) covering approximately 25,031 annual tests with immunoassay screening and LC/MS/MS or GC/MS confirmation; and the City of Austin's June 2026 IFB for rapid HIV test kits (due July 17, 2026) with estimated annual quantities of 375 Abbott Determine combo test units. The Illinois Department of Public Health also conducted two emergency sole-source procurements from Abbott Laboratories in February and May 2026 for HIV and syphilis reagents to maintain CLIA certification and testing continuity at its Carbondale Laboratory.